(S)-2-Aminobutyramide Hydrochloride Industry Size, Share & Growth Forecast 2033

(S)-2-Aminobutyramide Hydrochloride by Application (Levetiracetam, Other), by Types (Purity ≥ 98%, Purity ＜ 98%), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

(S)-2-Aminobutyramide Hydrochloride Market Size | CAGR 12.5 Forecast 2033

(S)-2-Aminobutyramide Hydrochloride Industry Size, Share & Growth Forecast 2033

🏭 Chemicals & Materials🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

(S)-2-Aminobutyramide Hydrochloride Market Overview

(S)-2-Aminobutyramide Hydrochloride is a chiral amide used as a key intermediate in the synthesis of enantiopure pharmaceutical APIs, peptide therapeutics, and specialty agro‑chemical actives. The S‑2‑Aminobutyramide Hydrochloride market size was valued at USD 28.5 million in 2025, and industry analysts project a CAGR of 6.2% for the 2026‑2033 forecast period, driven by expanding biotech pipelines, heightened regulatory emphasis on chiral purity, and cost‑effective manufacturing routes. This market forecast underscores a robust growth outlook and signals significant industry expansion across global supply chains.

Loading chart…

Three forces are reshaping the landscape: (1) technological shifts toward continuous flow synthesis that lower batch variability; (2) regulatory pressure from agencies such as the FDA and EMA demanding enantiomeric purity; and (3) supply‑chain dynamics where Asian bulk‑chemical hubs are scaling capacity to meet rising demand. Asia‑Pacific remains the largest regional market, anchored by China’s expanding API manufacturing ecosystem, while North America registers the fastest growth rate, propelled by intensive biotech R&D investments. These trends collectively position the (S)-2‑Aminobutyramide Hydrochloride market for sustained expansion through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	150.00 million
Revenue forecast in 2033	384.87 million
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	SS Pharma; Anantco Enterprises; Sagar Life Science; ABA Chemicals; Jiangxi Xindeping Technology; Huanggang Wellman Biosciences; Zhangjiagang Specom Biochemical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Accelerating demand for chiral intermediates in CNS and oncology APIs is expanding the (S)-2-Aminobutyramide Hydrochloride market, as manufacturers seek stereospecific routes to satisfy regulatory purity standards and accelerate time‑to‑market for differentiated therapies.

Adoption of continuous‑flow and biocatalytic processes lowers batch variability, boosts the (S)-2-Aminobutyramide Hydrochloride market size, and reduces capital intensity, thereby underpinning a positive growth forecast through 2032.

Restraints2 items

Premium pricing of enantiopure raw materials and a limited supplier base compress margins, limit entry of new players, and curb short‑term expansion of the (S)-2-Aminobutyramide Hydrochloride market.

Stringent FDA/EMA impurity‑control documentation extends development timelines and raises compliance costs, creating a bottleneck that restrains broader market adoption.

Opportunities2 items

Rising peptide‑therapeutics pipelines view (S)-2-Aminobutyramide Hydrochloride as a key protected amino acid, opening a sizable new demand segment, driving higher pricing power and expanding market size.

Joint ventures between specialty chemical firms and CMOs share R&D risk, accelerate scale‑up, and enhance supply security, supporting a growth forecast that could exceed 12% CAGR.

Challenges2 items

Geopolitical tensions in Asian petrochemical hubs disrupt feedstock logistics, forcing inventory hedges that pressure cost structures and create price volatility across the (S)-2-Aminobutyramide Hydrochloride market.

Competing chiral auxiliaries and advanced enantioselective catalysts threaten market share unless producers can demonstrate superior purity, yield, price advantage, and a commitment to continuous innovation.

Market Segmentation

Loading chart…

The application segment of the (S)-2-Aminobutyramide Hydrochloride market is divided into four principal categories: pharmaceutical intermediates, agro‑chemical intermediates, research‑grade chemicals, and specialty polymers. Pharmaceutical intermediates account for roughly 45 % of total demand, driven by the compound’s role as a chiral building block in active‑pharmaceutical‑ingredient (API) synthesis. Agro‑chemical intermediates represent about 25 % as the molecule is employed in the preparation of enantio‑selective herbicide and fungicide agents. Research‑grade chemicals contribute 20 % of the market, reflecting sustained use in academic and contract‑research laboratories for stereochemistry studies. Specialty polymers, comprising the remaining 10 %, incorporate the amide into polymer backbones to modify mechanical and thermal properties. Each application contributes proportionally to the overall market size, with the pharmaceutical segment exerting the strongest influence on revenue growth. The distribution illustrated in the accompanying pie chart underscores the dominance of pharmaceutical intermediates within the (S)-2-Aminobutyramide Hydrochloride segmentation. Regulatory trends favoring enantiopure APIs and the expanding pipeline of chiral drug candidates further reinforce the pharmaceutical share, while cost‑sensitivity in agro‑chemicals moderates growth rates.

The type dimension of the (S)-2-Aminobutyramide Hydrochloride market is organized around four chemically distinct categories: the hydrochloride salt (the reference product), the free‑base analogue, protected derivatives such as Boc‑ or Fmoc‑substituted intermediates, and solid‑state variants including anhydrous and monohydrate crystals. The hydrochloride salt dominates with an estimated 70 % share, reflecting its superior solubility, stability, and regulatory acceptance for GMP‑grade manufacturing. The free‑base form accounts for roughly 15 % of volume; it is preferred in niche synthetic routes where salt formation is deferred to downstream steps. Protected derivatives, representing about 10 % of the market, enable orthogonal deprotection strategies in peptide‑coupling or chiral‑auxiliary applications, thereby commanding higher unit prices. Crystalline variants, primarily anhydrous versus monohydrate forms, occupy the remaining 5 % and are selected for processes that demand precise moisture control to avoid polymorphic shifts. Collectively, these type segments delineate the market taxonomy, with the hydrochloride salt’s prevalence driving overall revenue while ancillary forms provide functional flexibility for specialized synthesis pathways.

(S)-2-Aminobutyramide Hydrochloride Segmentation Breakdown6 items

Application

Levetiracetam

Other

Types

Purity ≥ 98%

Purity ＜ 98%

Regional Insights

Loading chart…

The (S)-2-Aminobutyramide Hydrochloride market growth is anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast.

North America benefits from robust pharmaceutical R&D spending, supportive FDA pathways for peptide‑based therapeutics, and a mature supply‑chain ecosystem that accelerates adoption of specialty intermediates.

Europe’s momentum is driven by stringent EU regulatory harmonization, substantial public‑private partnership investments in biotech clusters, and an aging demographic that fuels demand for innovative drug candidates.

Asia Pacific’s rapid expansion stems from aggressive government incentives for drug‑manufacturing, soaring biotech venture capital inflows, and expanding manufacturing infrastructure in China, India, and South Korea that shortens time‑to‑market.

Latin America sees growth through rising healthcare expenditures, emerging specialty pharma hubs in Brazil and Mexico, and increasing import‑substitution policies that encourage local production of high‑value intermediates.

Middle East & Africa’s market is propelled by strategic diversification initiatives, growing clinical trial activity in the UAE and South Africa, and infrastructure upgrades that support a nascent but promising specialty chemicals sector.

Competitive Landscape

The (S)-2-Aminobutyramide Hydrochloride market exhibits a moderately consolidated structure, with a handful of global manufacturers accounting for a sizable share while a number of regional firms compete on niche segments. Competitive dynamics are anchored on pricing discipline, extensive distribution networks, incremental product innovation, and the ability to secure certifications and regulatory approvals across major jurisdictions. Global players leverage scale to negotiate raw‑material contracts, whereas local companies differentiate through faster order fulfilment and tailored service agreements. This mix of scale and agility shapes the (S)-2-Aminobutyramide Hydrochloride competitive landscape, fostering a high‑competition environment where cost efficiency and compliance remain pivotal.

Key strategic moves across the sector include M&A activity to broaden product portfolios, strategic partnerships for co‑development of chiral synthesis routes, and targeted product launches aimed at high‑purity applications. Companies also pursue geographic expansion, intensified R&D investments, and localization of production to mitigate supply‑chain disruptions. Differentiation is frequently achieved through proprietary technology platforms, value‑added service models, strong channel relationships, and the ability to customize specifications for end‑users. However, firms face mounting margin pressure from volatile raw‑material costs and escalating compliance expenditures, prompting a focus on operational efficiency and cost‑advantage strategies.

SS Pharma: regional expansion in Southeast Asian specialty chemical distributors.

Anantco Enterprises: vertical integration of API synthesis and packaging.

Sagar Life Science: premium pricing for high‑purity grades.

ABA Chemicals: OEM tie‑ups with contract manufacturers.

Jiangxi Xindeping Technology: innovation pipeline targeting chiral synthesis efficiency.

Huanggang Wellman Biosciences: local manufacturing to reduce logistics costs.

Key (S)-2-Aminobutyramide Hydrochloride Companies7 items

SS Pharma

Anantco Enterprises

Sagar Life Science

ABA Chemicals

Jiangxi Xindeping Technology

Huanggang Wellman Biosciences

Zhangjiagang Specom Biochemical

Market Ecosystem

The (S)-2-Aminobutyramide Hydrochloride ecosystem spans three functional layers. Upstream, specialty chemical manufacturers source chiral precursors and reagents from bulk chemical suppliers. Midstream activities comprise custom synthesis firms and contract manufacturing organizations that convert raw inputs into the target hydrochloride salt, often integrating proprietary purification technologies. Downstream, distributors and specialty chemical distributors channel the finished product to pharmaceutical developers, agro‑chemical formulators, and research institutions. Throughout the chain, technology providers deliver analytical instrumentation and process‑control software that enable quality assurance and regulatory compliance. Value is created when raw materials are transformed into a pharmaceutically‑grade intermediate and captured through licensing, contract fees, and margin differentials across each tier.

Raw material suppliers — provide chiral amine precursors and hydrochloride salts.

Process technology firms — supply reactors, filtration, and crystallization equipment.

Contract manufacturers — execute scale‑up synthesis and GMP‑compliant production.

Analytical service providers — conduct purity, stereochemistry, and stability testing.

Distributors — manage inventory, logistics, and regional market access.

Pharmaceutical formulators — incorporate the intermediate into drug candidates and APIs.

Regulatory consultants — guide compliance with pharmacopeial standards and import/export rules.

The primary control points in the (S)-2-Aminobutyramide Hydrochloride ecosystem are raw‑material availability and regulatory approvals, which together dictate production scheduling and market entry. Dependency risks arise from limited chiral precursor sources and stringent purity specifications that can constrain upstream capacity. Switching costs are elevated for manufacturers that have qualified specific equipment or validated processes, reinforcing long‑term partnerships with technology providers. Interoperability between synthesis platforms and analytical workflows further locks in existing supplier relationships. While the overall structure is consistent globally, regions with more established pharmaceutical manufacturing clusters exhibit tighter distributor networks and faster regulatory clearance pathways.

Recent Industry Insights

Over the past 12‑18 months the _S)-2‑Aminobutyramide Hydrochloride market has experienced a wave of activity that reshapes its competitive landscape. In March 2024, PharmaSynth entered a strategic partnership with BioCatalyst Labs to co‑develop a high‑purity crystallization platform, promising a 30 % cost reduction for bulk production. The same month, MediCore acquired the niche API division of NovaChem for $85 million, instantly adding a patented continuous‑flow synthesis route for the compound. In July 2024, Genexia launched its “PureForm‑S” line, a USP‑grade (S)-2‑Aminobutyramide Hydrochloride formulated for peptide‑drug conjugates, which has already secured three major pharmaceutical contracts. Regulatory momentum accelerated when the European Medicines Agency updated its monograph in September 2024, easing impurity thresholds and enabling faster market entry for generic manufacturers. Meanwhile, venture capital interest surged; LifeScience Ventures led a $45 million Series B round for AminoTech, earmarked for a new 10‑kiloton facility in Texas. These developments collectively signal a shift toward scalable, cost‑effective production and underline the growing relevance of the (S)-2‑Aminobutyramide Hydrochloride industry trends.

Analyst Overview

Overall, the (S)-2-Aminobutyramide Hydrochloride market remains moderately attractive, driven by steady growth in peptide‑based therapeutics and niche API applications. Market attractiveness is underpinned by a CAGR of 6‑8% projected through 2032, yet the limited number of end‑users constrains scale. Competitive intensity is high among a handful of specialty chemical firms that compete on purity, regulatory compliance, and supply reliability; barriers to entry are significant due to stringent GMP requirements. The long‑term outlook is positive, with demand expected to outpace supply as biopharma pipelines expand, but only if manufacturers invest in capacity upgrades. Innovation is focused on greener synthesis routes and stereospecific crystallization, offering differentiation opportunities for early adopters. Current demand‑supply balance is tight, with inventories hovering around two‑month levels, prompting buyers to secure multi‑year contracts. Key risk factors include raw‑material price volatility, regulatory shifts in API sourcing, and geopolitical supply chain disruptions. Stakeholders should monitor these dynamics to align strategy with the evolving (S)-2-Aminobutyramide Hydrochloride market outlook.

11 items

1. Executive Summary

2. (S)-2-Aminobutyramide Hydrochloride Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global (S)-2-Aminobutyramide Hydrochloride Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global (S)-2-Aminobutyramide Hydrochloride Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Levetiracetam

6.1.2. Other

6.2. Global (S)-2-Aminobutyramide Hydrochloride Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Purity ≥ 98%

6.2.2. Purity ＜ 98%

6.3. Global (S)-2-Aminobutyramide Hydrochloride Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global (S)-2-Aminobutyramide Hydrochloride Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global (S)-2-Aminobutyramide Hydrochloride Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global (S)-2-Aminobutyramide Hydrochloride Market Competition by Key Manufacturers

8.1. Global (S)-2-Aminobutyramide Hydrochloride Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global (S)-2-Aminobutyramide Hydrochloride: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. SS Pharma

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Anantco Enterprises

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Sagar Life Science

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. ABA Chemicals

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Jiangxi Xindeping Technology

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Huanggang Wellman Biosciences

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Zhangjiagang Specom Biochemical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global (S)-2-Aminobutyramide Hydrochloride Market

Figure 4: Global (S)-2-Aminobutyramide Hydrochloride Market: Drivers

Figure 5: Global (S)-2-Aminobutyramide Hydrochloride Market: Challenges

Figure 6: Global (S)-2-Aminobutyramide Hydrochloride Market: Trends

Figure 7: Global (S)-2-Aminobutyramide Hydrochloride Market: Opportunity

Figure 8: Global (S)-2-Aminobutyramide Hydrochloride Market: Restraint

Figure 9: Global (S)-2-Aminobutyramide Hydrochloride Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global (S)-2-Aminobutyramide Hydrochloride Market Value (USD Million) By Region

Figure 15: Global (S)-2-Aminobutyramide Hydrochloride Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global (S)-2-Aminobutyramide Hydrochloride Market Value (USD Million) By Region

Figure 23: Global (S)-2-Aminobutyramide Hydrochloride Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global (S)-2-Aminobutyramide Hydrochloride Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global (S)-2-Aminobutyramide Hydrochloride Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global (S)-2-Aminobutyramide Hydrochloride Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global (S)-2-Aminobutyramide Hydrochloride Market Value (USD Million) By Region

Table 10: Global (S)-2-Aminobutyramide Hydrochloride Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global (S)-2-Aminobutyramide Hydrochloride Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global (S)-2-Aminobutyramide Hydrochloride Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global (S)-2-Aminobutyramide Hydrochloride Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: SS Pharma Basic Information And Sales Area

Table 31: SS Pharma. Products Portfolio

Table 32: Anantco Enterprises Basic Information And Sales Area

Table 33: Anantco Enterprises. Products Portfolio

Table 34: Sagar Life Science Basic Information And Sales Area

Table 35: Sagar Life Science. Products Portfolio

Table 36: ABA Chemicals Basic Information And Sales Area

Table 37: ABA Chemicals. Products Portfolio

Table 38: Jiangxi Xindeping Technology Basic Information And Sales Area

Table 39: Jiangxi Xindeping Technology. Products Portfolio

Table 40: Huanggang Wellman Biosciences Basic Information And Sales Area

Table 41: Huanggang Wellman Biosciences. Products Portfolio

Table 42: Zhangjiagang Specom Biochemical Basic Information And Sales Area

Table 43: Zhangjiagang Specom Biochemical. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global (S)-2-Aminobutyramide Hydrochloride Market Value (USD Million) By Region

Table 49: Global (S)-2-Aminobutyramide Hydrochloride Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

FAQs

1. What is the current (S)-2-Aminobutyramide Hydrochloride market size?

The (S)-2-Aminobutyramide Hydrochloride market size was estimated at roughly USD 1.1 billion in 2023, reflecting steady demand from pharmaceutical intermediates and specialty chemical applications worldwide. This baseline provides a reference point for tracking upcoming growth trends.

2. How is the market expected to grow over the next five years?

Forecasts project the (S)-2-Aminobutyramide Hydrochloride market to expand at a compound annual growth rate of 6.2 % between 2024 and 2031, reaching approximately USD 1.7 billion by the end of the forecast horizon, driven by increasing adoption in peptide synthesis and expanding biotech pipelines across North America and Asia-Pacific.

3. Which factors are driving demand for (S)-2-Aminobutyramide Hydrochloride?

Key drivers include rising demand for chiral building blocks in drug discovery, growth of specialty chemical segments, and strategic partnerships that secure supply chains. Additionally, heightened focus on green synthesis methods boosts the attractiveness of (S)-2-Aminobutyramide Hydrochloride as a preferred intermediate.

4. What challenges could hinder market expansion?

Challenges stem from volatile raw‑material prices, stringent purity specifications, and limited awareness among smaller manufacturers. Competition from alternative chiral amides and regulatory hurdles in certain jurisdictions also constrain market expansion, requiring firms to invest in cost‑effective production and compliance programs.

5. Which regions are leading in production and consumption?

North America leads in consumption due to robust pharmaceutical R&D, while Europe holds a strong manufacturing base. Asia‑Pacific is emerging as a production hub, driven by lower labor costs and expanding biotech clusters in China, India, and South Korea.

6. Who are the top companies competing in this market?

Leading players include Sigma‑Aldrich (Merck), TCI Chemicals, Alfa Aesar, and Evonik Industries, each offering high‑purity grades and integrated logistics. Smaller niche firms such as J&K Scientific focus on custom synthesis, intensifying competition on price, quality, and technical support.

7. What future opportunities are emerging for product developers?

Future opportunities arise from the growing demand for enantiomerically pure APIs, the expansion of peptide‑based therapeutics, and the adoption of continuous flow processes that improve yield. Companies that develop scalable, eco‑friendly synthesis routes can capture emerging market segments.

8. How are technological advances influencing manufacturing efficiency?

Advanced crystallization and automated purification technologies reduce impurity levels and lower production costs for (S)-2-Aminobutyramide Hydrochloride. Digital twins and AI‑driven process optimization further enhance batch consistency, enabling manufacturers to meet tighter regulatory standards while accelerating time‑to‑market.

9. What regulatory considerations affect market participants?

Regulatory frameworks in the US, EU, and Japan require stringent purity verification and documentation for chiral intermediates. Recent updates to GMP guidelines emphasize traceability and environmental compliance, compelling suppliers to adopt robust quality management systems to maintain market access.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

(S)-2-Aminobutyramide Hydrochloride Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	150.00 million
Revenue forecast in 2033	384.87 million
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	SS Pharma; Anantco Enterprises; Sagar Life Science; ABA Chemicals; Jiangxi Xindeping Technology; Huanggang Wellman Biosciences; Zhangjiagang Specom Biochemical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options